Literature DB >> 8925720

The pharmacology, metabolism, and chemistry of clofazimine.

R O'Connor1, J F O'Sullivan, R O'Kennedy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8925720     DOI: 10.3109/03602539508994208

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  25 in total

1.  Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.

Authors:  Thomas M Reeves; Patricia A Trimmer; Beverly S Colley; Linda L Phillips
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

2.  Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition.

Authors:  Rahul K Keswani; Jason Baik; Larisa Yeomans; Chuck Hitzman; Allison M Johnson; Ashtamurthy S Pawate; Paul J A Kenis; Nair Rodriguez-Hornedo; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

3.  A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages.

Authors:  Rahul K Keswani; Gi S Yoon; Sudha Sud; Kathleen A Stringer; Gus R Rosania
Journal:  Cytometry A       Date:  2015-06-24       Impact factor: 4.355

Review 4.  Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Authors:  J G Douglas; M J McLeod
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

5.  Molecular imaging of intracellular drug-membrane aggregate formation.

Authors:  Jason Baik; Gus R Rosania
Journal:  Mol Pharm       Date:  2011-08-12       Impact factor: 4.939

6.  Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species.

Authors:  Takahiro Yano; Sacha Kassovska-Bratinova; J Shin Teh; Jeffrey Winkler; Kevin Sullivan; Andre Isaacs; Norman M Schechter; Harvey Rubin
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

7.  Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.

Authors:  Nicole C Ammerman; Rosemary V Swanson; Elaine M Bautista; Deepak V Almeida; Vikram Saini; Till F Omansen; Haidan Guo; Yong Seok Chang; Si-Yang Li; Asa Tapley; Rokeya Tasneen; Sandeep Tyagi; Fabrice Betoudji; Chivonne Moodley; Bongani Ngcobo; Logan Pillay; Linda A Bester; Sanil D Singh; Richard E Chaisson; Eric Nuermberger; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 8.  A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment.

Authors:  Russell R Kempker; Wael A Alghamdi; Mohammad H Al-Shaer; Gena Burch; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

9.  Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response.

Authors:  Jason Baik; Kathleen A Stringer; Gerta Mane; Gus R Rosania
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

10.  Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.

Authors:  Yasuhiro Horita; Norio Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.